Market Overview

UPDATE: JP Morgan Raises PT to $62 on Health Care REIT Post Q2

Share:
Related HCN
Earnings Scheduled For November 7, 2017
Earnings Scheduled For July 28, 2017
Welltower Is Well Worth Buying At These Prices (Seeking Alpha)

JP Morgan reiterated its Overweight rating on Health Care REIT (NYSE: HCN) and increased its price target from $61 to $62.

JP Morgan commented, "Our OW rating on HCN is based on a number of factors including our belief that the stock has above-average growth prospects relative to the health care sector, and we see valuation attractive based on discounted trading multiples and an above-average dividend yield."

Health Care REIT closed at $60.17 on Thursday.

Latest Ratings for HCN

DateFirmActionFromTo
Nov 2017Stifel NicolausMaintainsBuy
Oct 2017UBSMaintainsNeutral
Sep 2017Bank of AmericaMaintainsNeutral

View More Analyst Ratings for HCN
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Reiteration Intraday Update Analyst Ratings

 

Related Articles (HCN)

View Comments and Join the Discussion!